Browse All

Current Filters

CLEAR FILTER x

TITLE

Topic:

Modulation of Sleep Physiology by Nocturnal Deep Brain Stimulation Amplitude in Parkinson’s Disease

The First Light: Efficacy and Safety of a Multi-dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor Two Agonist for the Treatment of Narcolepsy Type One

Enhancing Glymphatic Transport via Vasopressin: Implications for Neurodegenerative Disease and Drug Delivery

Changes in Self-Reported Cognitive Complaints, Functional Impairments, Work Productivity, and Symptom Severity in Participants With Narcolepsy After Treatment With Greater Than 9 Gram Dosages of Low-Sodium Oxybate in the DUET Study